• AZD3463: Oral ALK Inhibitor for Neuroblastoma Research Ex...

  2026-01-21

  AZD3463 delivers highly selective, dual ALK/IGF1R inhibition for neuroblastoma models, including those with crizotinib resistance and activating ALK mutations. With robust induction of apoptosis and autophagy, and synergy in combination therapy, AZD3463 from APExBIO empowers researchers to overcome experimental bottlenecks in ALK-driven cancer research.

• Okadaic Acid (SKU A4540): Reliable Phosphatase Inhibition...

  2026-01-20

  This article addresses critical experimental challenges in cell viability, apoptosis, and signal transduction studies, demonstrating how Okadaic acid (SKU A4540) enables reproducible, data-driven results. Drawing from peer-reviewed literature and practical laboratory scenarios, it details the mechanistic advantages and workflow optimizations achieved with Okadaic acid, guiding researchers seeking robust phosphatase inhibition and assay reliability.

452 records 31/31 page Previous First page 上5页 31